Ann Arbor USA  
Select Category:
Business Resources  |   Site Selectors  |   Community  |   Career Services  |   Events  |   About Us  |  

Logo
 
  Home / Business Resources / Success Stories / AAPharmaSyn

AAPharmaSyn

AAPharmaSyn Awarded $750,000 from 21st Century Jobs Fund
AAPharmaSyn, a global research organization specializing in medicinal chemistry research, was recently awarded $750,000 from the State of Michigan’s 21st Century Jobs Fund as seed money to start a lab in Ann Arbor.

Ann Arbor SPARK worked closely with AAPharmaSyn on the proposal, presentation and strategic approach to apply for funding from the Michigan Economic Development Corporation.

“Without the encouragement and help from Ann Arbor SPARK, AAPharmaSyn would not be where it is today,” said Helen Lee, president and founder, AAPharmaSyn. “The funding received from the 21st Century Jobs fund supports AAPharmaSyn’s expansion and growth at a critical time in the company’s development.” 

Founded by a group of synthetic organic and medicinal chemists with more than 50 combined years of successful drug discovery and development experience, AAPharmaSyn is a global Contract Research Organization (CRO). The company specializes in medicinal chemistry research and custom synthesis services for the drug discovery needs of academic institutions, small to medium-size pharmaceutical companies and biotech companies.

Michigan Innovation Equipment Depot (MIED) Helps Out Too
AAPharmaSyn also received valuable life sciences equipment from the Michigan Innovation Equipment Depot (MIED), a collaborative efforts of Ann Arbor SPARK, MichBio and Pfizer, Inc. The MIED makes life sciences equipment, donated by Pfizer, available to start-up life sciences companies throughout the state, providing a critical resource to early stage companies.

Over the coming year, AAPharmaSyn plans to evolve its services to support potential clients in the following areas:
  • Drug screen hit structure evaluation
  • Hit to lead and lead optimization
  • SAR strategy design and execution
  • Parachuting strategy design and execution
  • Structural modifications to address PK/PD and early toxicology issues
  • Reference agents recommendation and synthesis
  • Custom synthesis of organic compounds, medium to large scale

Printer Friendly Page Email this page to a friend

 
“Without the encouragement and help from Ann Arbor SPARK, AAPharmaSyn would not be where it is today.”

Helen Lee
President and Founder
AAPharmaSyn

AAphrmsyn Logo